Skip to content
PatentBrief
Get alertsTop ↑

Using AI to Design Drugs by Understanding Molecular Shapes

This patent describes a computer system that uses advanced math to describe molecule shapes and then feeds that information into artificial intelligence to predict how well potential drugs will work or if they'll be toxic.

ActiveExpires 2039Owned by Michigan State UniversityInvented by Guowei Wei, Zixuan Cang, Duc Nguyen

Original patent title: “System and methods for machine learning for drug design and discovery”

Plain-English explanation by SahiLast reviewed · November 2, 2026

This patent describes a computer system that uses advanced math to describe molecule shapes and then feeds that information into artificial intelligence to predict how well potential drugs will work or if they'll be toxic. Owned by Michigan State University with 23 claims and 101 forward citations, and it is expected to expire in 2039.

Coverage

What does this patent actually cover?

The system identifies potential drug compounds based on desired characteristics or clinical applications (ClaimclaimA numbered sentence at the end of a patent that legally defines what the inventor owns. The most important section.Read more → 1). It then uses special mathematical techniques like "persistent homology" and "graph theory" to create "feature data" that describes their complex 3D structures (AbstractabstractA short summary at the front of the patent describing the invention. Not legally binding.Read more →, Claim 1). This feature data, which can include "element specific topological fingerprint records" (Claim 3) or "interactive element specific persistent homology barcodes" (Claim 4), is then fed into "trained machine learning models" (Claim 1). These models predict important characteristics, such as "protein binding affinity" (Claim 3) or "protein folding energy change upon mutation" (Claim 4). Finally, the system displays an "ordered list" of the most promising compounds based on these predictions (Claim 1, Claim 2). For example, it could predict which new molecule will bind most effectively to a specific protein target.

The gap

What does this patent NOT cover?

  • Does not cover drug design methods that do not use machine learning to predict molecular characteristics.
  • Does not cover predicting molecular characteristics without using feature data derived from persistent homology or graph theory.
  • Does not cover systems that predict drug properties without displaying an ordered list of candidate compounds.
  • Does not cover traditional drug screening methods that rely solely on laboratory experiments without computational prediction.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 20190304568
StatusActive
FieldBiotech & Medicine
AssigneeMichigan State University
InventorsGuowei Wei, Zixuan Cang, Duc Nguyen
Filed2019
Expires2039
Claims23
Times cited101
LitigationNone on record
Value · $624K–$2.0MSubstantial

What made this novel

The noveltynoveltyThe requirement that an invention be different from anything publicly known before its priority date.Read more → lies in combining sophisticated mathematical tools like persistent homology and graph theory to capture the complex, multi-scale geometric and topological features of molecules, and then feeding these unique "fingerprints" into powerful machine learning algorithms to accurately predict molecular characteristics. This allows the AI to "see" and understand molecular shapes in a way that was previously difficult for computers.

The Patent Drawing

Representative patent drawing for System and methods for machine learning for drug design and discovery (US 20190304568)
Representative figure · US 20190304568All figures on Google Patents →
System and methods for machine…(Primary claim)pharmaceuticalbiotechsoftwareai mlmaterials

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Computational drug discovery platforms

02

AI-driven pharmaceutical research

03

Virtual screening for new drug candidates

04

Predicting protein-ligand interactions

05

Optimizing drug toxicity profiles

Why it matters

The bigger picture

Drug discovery is a long, expensive process. This patent aims to speed it up significantly by using computers to predict how potential drugs will behave before they are even synthesized or tested in a lab. By identifying promising compounds earlier, it could reduce costs and accelerate the development of new medicines, making the process more efficient.

Filed

April 1, 2019

Market context

Who's building on this

Companies in this space

Major pharmaceutical companies like Pfizer, Novartis, and AstraZeneca are investing heavily in AI for drug discovery. Startups such as Recursion Pharmaceuticals, BenevolentAI, and Insilico Medicine are also developing similar computational platforms. Academic institutions like Michigan State University continue to advance research in this area, often collaborating with industry partners.

Market impact

This technology contributes to the growing field of in silico (computer-based) drug discovery, which aims to reduce the time and cost of bringing new drugs to market. It enables faster identification of promising drug candidates and better prediction of their properties, potentially leading to more efficient R&D pipelines and a shift away from purely experimental screening methods. This could significantly reshape how pharmaceutical research and development are conducted.

Claim 1 — Plain English

What this patent covers

The system identifies potential drug compounds based on desired characteristics or clinical applications (Claim 1). It then uses special mathematical techniques like "persistent homology" and "graph theory" to create "feature data" that describes their complex 3D structures (Abstract, Claim 1). This feature data, which can include "element specific topological fingerprint records" (Claim 3) or "interactive element specific persistent homology barcodes" (Claim 4), is then fed into "trained machine learning models" (Claim 1). These models predict important characteristics, such as "protein binding affinity" (Claim 3) or "protein folding energy change upon mutation" (Claim 4). Finally, the system displays an "ordered list" of the most promising compounds based on these predictions (Claim 1, Claim 2). For example, it could predict which new molecule will bind most effectively to a specific protein target.

The clever bit

The novelty lies in combining sophisticated mathematical tools like persistent homology and graph theory to capture the complex, multi-scale geometric and topological features of molecules, and then feeding these unique "fingerprints" into powerful machine learning algorithms to accurately predict molecular characteristics. This allows the AI to "see" and understand molecular shapes in a way that was previously difficult for computers.

What it does not cover

  • Does not cover drug design methods that do not use machine learning to predict molecular characteristics.
  • Does not cover predicting molecular characteristics without using feature data derived from persistent homology or graph theory.
  • Does not cover systems that predict drug properties without displaying an ordered list of candidate compounds.
  • Does not cover traditional drug screening methods that rely solely on laboratory experiments without computational prediction.

Patent timeline

Filing

Application submitted to the patent office

Expiration

Patent enters public domain

PatentBrief Score

Impact Score

Moderate

Citation count

40/40

Highly cited

Claim breadth

15/20

Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

0/20

Older than 20 years

Assignee scale

0/20

Independent or smaller assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Substantial

$624K – $2.0M

Midpoint $1.2M · 12.4 yr remaining · industry ×1.6

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

The original legal language

Original claims

23 claims as filed with the patent office.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cites earlier patents

5

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

101

later patents that build on this invention

View patents →

Cite this patent

Wei, G., Cang, Z., & Nguyen, D. Using AI to Design Drugs by Understanding Molecular Shapes (U.S. Patent No. 20,190,304,568). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/20190304568/system-and-methods-for-machine-learning-for-drug-design-and-discovery

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US20190304568"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary
Explore the landscape:pharmaceutical patents →biotech patents →software patents →

Common Questions

Frequently Asked Questions

What does Using AI to Design Drugs by Understanding Molecular Shapes cover?

This patent describes a computer system that uses advanced math to describe molecule shapes and then feeds that information into artificial intelligence to predict how well potential drugs will work or if they'll be toxic.

Who owns patent US 20190304568?

This patent is owned by Michigan State University.

When does this patent expire?

This patent is expected to expire on April 1, 2039, when the invention enters the public domain.

What is patent US 20190304568 cited by?

This patent has been cited by 101 later patents that build on its ideas.

What problem does this patent solve?

Drug discovery is a long, expensive process. This patent aims to speed it up significantly by using computers to predict how potential drugs will behave before they are even synthesized or tested in a lab. By identifying promising compounds earlier, it could reduce costs and accelerate the development of new medicines, making the process more efficient.

What does this patent NOT cover?

Does not cover drug design methods that do not use machine learning to predict molecular characteristics.

Patent monitoring

Get notified when Michigan State University files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: November 2, 2026 · PatentBrief is not a law firm and this is not legal advice.